Fundraising Fox

Facible BioDiagnostics

Meridian, US · Founded 2019 · Delaware corporation

Biotech

Founders & leadership

CG
Clementine Gibard BohachekNamed on SEC filing
SB
Steven BurdenNamed on SEC filing
CW
Casi WyattNamed on SEC filing
MH
Matthew HawkinsNamed on SEC filing
MK
Micah KormyloNamed on SEC filing
EH
Eric HaydenNamed on SEC filing
BF
Brent FawsonNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$3.7M disclosed across 2 rounds · 2021–2022

▶$861.9KraisedMay 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew HawkinsDirector
  • Clementine Gibard BohachekExecutive Officer
  • Eric HaydenDirector
  • Steven BurdenExecutive Officer, Director
  • Brent FawsonExecutive Officer
  • Micah KormyloExecutive Officer
  • Casi WyattDirector
Offering amount
$1.8M
Amount sold
$861.9K
First sale
May 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.8MraisedMay 2022 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Clementine Gibard BohachekExecutive Officer
  • Steven BurdenExecutive Officer, Director
  • Casi WyattDirector
  • Matthew HawkinsDirector
  • Micah KormyloExecutive Officer
  • Eric HaydenDirector
  • Brent FawsonExecutive Officer
Offering amount
$2.8M
Amount sold
$2.8M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Facible BioDiagnostics raised?
Facible BioDiagnostics has disclosed $3.7M raised across 2 rounds.
Where is Facible BioDiagnostics headquartered?
Facible BioDiagnostics is headquartered in Meridian, US.